Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy

BACKGROUND: Epilepsy affects over 65 million people worldwide and significantly burdens patients, caregivers, and society. Drug-resistant epilepsy occurs in approximately 30% of patients and growing evidence indicates that oxidative stress contributes to the development of such epilepsies. Activatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandouka, Sereen, Singh, Prince Kumar, Saadi, Aseel, Taiwo, Rhoda Olowe, Sheeni, Yara, Zhang, Taige, Deeb, Larin, Guignet, Michelle, White, Steve H., Shekh-Ahmad, Tawfeeq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634153/
https://www.ncbi.nlm.nih.gov/pubmed/37940957
http://dx.doi.org/10.1186/s12967-023-04695-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634153/
https://www.ncbi.nlm.nih.gov/pubmed/37940957
http://dx.doi.org/10.1186/s12967-023-04695-2

Ejemplares similares